(Press-News.org) Approximately half of all Americans do not take their medication as prescribed by their doctor. This medication non-adherence causes an estimated 125,000 additional deaths and as much as $300 billion a year in additional medical appointments, emergency department visits, and hospitalizations.
A new study published in the Journal of the American Medical Association (JAMA) Network Open finds Amazon Pharmacy’s subscription service for common medications, RxPass, leads to significant improvements in medication adherence while reducing out-of-pocket costs for patients. This first-of-its-kind study evaluated the potential of subscription models to support prescription medication access and adherence.
The peer-reviewed research found that enrollment in RxPass led to subscribers having 27% more of their medication on-hand compared with customers not enrolled in the program, enabling them to be clinically adherent to their medications. Similarly, subscribers were 29% more likely to refill their medications. Enrollment was also associated with a decrease in out-of-pocket spending of $2.35 per month, a 30% decrease.
A promising tool for medication management
“This study suggests RxPass is a promising tool to improve medication management among patients with chronic conditions, especially those who take multiple medications and may have a limited income," said Dr. Vin Gupta, Chief Medical Officer at Amazon Pharmacy. "RxPass is a simple option for a significant problem in healthcare. Addressing medication non-adherence can prevent further disease progression and reduce overall costs.”
Launched in January 2023, RxPass offers Prime members access to 60 prescription medications for a flat fee of $5 per month. The program provides affordable access to many of the most commonly prescribed medications including statins, anti-hypertensives, and antidepressants, which treat chronic conditions. RxPass medications help people manage high blood pressure, high cholesterol, anxiety—conditions that impact hundreds of millions of Americans.
The research, conducted by a team led by Senior Healthcare Research Scientist Kai Yeung, Ph.D., Pharm.D., of Amazon Health Services, compared a sample of approximately 5,000 RxPass enrollees and control subjects over a six-month period.
Non-adherence has many causes
Conditions such as cardiovascular disease, when not treated regularly with medication, can develop into more severe health issues including heart attack or stroke. Ongoing high blood pressure can lead to heart disease, stroke, or kidney failure.
"Patients face multiple barriers to medication adherence, making it a challenging issue to address across healthcare," Dr. Yeung said. "RxPass tackles patient challenges holistically, simplifying medication management by reducing both the financial and administrative burdens. Subscribers know the cost upfront, have medications delivered to their door, and benefit from 24/7 access to a pharmacist. Our early findings indicate a low-cost subscription model can be an effective tool to help patients get and stay on their medications.”
Subscription programs like RxPass leverage a number of cognitive and behavioral factors including transparent pricing, automatic subscription renewal, bundling of goods or services, and enhanced customer support to engage customers.
“Improving health is often reliant on a series of small, consistent steps,” said Dr. Gupta. “I’m excited by the promise of the subscription medication model for chronic care, and compelled by how it could evolve the way we think about supporting our patients.”
RxPass is one of many ways to save with Amazon Pharmacy
Launched in 2020, Amazon Pharmacy continues to expand its services by offering a range of convenient and cost-effective options for filling prescriptions including RxPass, the Prime prescription savings benefit, and automatic coupons. Paired with features like fast, free delivery and 24/7 access to pharmacists, Amazon Pharmacy is transforming the pharmacy experience to support customers seeking new value, convenience, and selection.
"At Amazon Pharmacy, we're dedicated to being a partner in our customers' health journeys,” said John Love, VP of Amazon Pharmacy. “Whether it's through RxPass, our 24/7 pharmacist access, or convenient delivery options, we're constantly innovating to support our customers in achieving their health goals."
About Amazon Pharmacy
Amazon Pharmacy is a full-service pharmacy available on Amazon—essentially, a pharmacy in your pocket. It offers most prescription medications, delivering them to customers' doors with free two-day shipping for Prime members and same-day delivery in eligible locations. Amazon Pharmacy is improving the pharmacy experience by providing 24/7 access to pharmacists, upfront pricing, and many ways to save. It accepts most insurance plans, automatically applies eligible manufacturer-sponsored coupons, and offers additional savings options for Prime members through RxPass and Prime Rx. For those managing multiple daily medications, Amazon Pharmacy supports PillPack, a service that sorts medications by time and day.
END
Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study finds
A study published in the Journal of the American Medical Association Network Open reveals enrollment in RxPass is associated with reduced out-of-pocket costs and higher medication refill rates, which help patients better manage disease.
2025-02-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Tufts University School of Medicine, ATI Physical Therapy launch first-of-its-kind collaboration to make physical therapy education and career advancement more accessible and affordable
2025-02-03
With demand for physical therapy services projected to increase 27 percent by 2030, Tufts University School of Medicine (TUSM) and ATI Physical Therapy (ATI), a leading provider of physical therapy services across the United States, are launching a joint initiative aimed at expanding the physical therapist workforce and making the Doctor of Physical Therapy (DPT) Programs at TUSM more accessible.
As part of the first-of-its-kind collaboration, TUSM and ATI will contribute scholarships each semester for up to 45 ATI employees in TUSM’s DPT programs each academic year. The accelerated ...
Could lycopene—a plant extract—be an effective antidepressant?
2025-02-03
Emerging evidence suggests that lycopene—a natural plant extract—may have antidepressant properties. New research in Food Science & Nutrition reveals the mechanisms behind its antidepressant effects.
In mice with depressive-like behaviors, brain analyses revealed impairments in the hippocampus. Lycopene treatment lessened these impairments and reversed the animals’ depressive-like traits.
Lycopene treatment boosted the expression of brain-derived neurotrophic factor (BDNF), a protein with roles in many aspects of brain function. Experiments indicated that a signaling pathway involving BDNF (called the BDNF-TrkB pathway, ...
Study shows urine test for prostate cancer could be used at home
2025-02-03
Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancer screening is highly accurate. The exciting new results, published in The Journal of Urology, build upon a prior Vanderbilt study of prostate cancer screening that required a digital rectal exam.
The results are important because this could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas.
Traditional prostate cancer screening with PSA testing and biopsy has been shown to lead to unnecessary procedures and overdiagnosis of low-grade cancers, according to ...
Shaping future of displays: clay/europium-based technology offers dual-mode versatility
2025-02-03
The world of display technology is on the cusp of a transformative breakthrough, with electrochemical stimuli-responsive materials gaining more attraction. Based on external stimuli, such as low voltage, these materials can instantaneously undergo electrochemical reactions. These electrochemical reactions can result in the production of different colors, revolutionizing the age of display solutions. An electrochemical system consists of electrodes and electrolytes. Combining the luminescent and coloration molecules on the electrodes instead of the electrolyte can offer higher efficiencies and stability for display devices.
To this end, a research team ...
Optimizing ADHD treatment: revealing key components of cognitive–behavioral therapy
2025-02-03
Attention-deficit hyperactivity disorder (ADHD) is a well-known neurodevelopmental disorder that affects the brain's ability to regulate attention and control impulses. It poses many challenges to those affected, typically making it difficult for them to sustain focus, follow through with instructions, and maintain a calm and restful state. As one of the most common neurodevelopmental disorders, ADHD impacts individuals throughout their lives, creating a breadth of social, emotional, academic, and workplace challenges.
Despite its high ...
Breaking barriers in thioxanthone synthesis: a double aryne insertion strategy
2025-02-03
Thioxanthones are fascinating organic compounds that have found their way into many industrial and everyday applications. In the printing industry, for example, they help inks dry faster when exposed to light thanks to their light-absorption properties, making the printing process quicker and more efficient. Some thioxanthones have been developed into FDA-approved drugs used to treat parasitic infections and cancer. Additionally, their effectiveness as photocatalysts has led some researchers to explore their potential as stabilizers against electrical breakdown. Thioxanthones have also been ...
Houston Methodist researchers identify inhibitor drugs to treat aggressive breast cancer
2025-02-03
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
Houston Methodist and a team of researchers from across the country examined the biology of metaplastic breast cancer, comparing it to non-metaplastic triple negative breast cancer. They discovered metaplastic breast cancers typically exhibit two unique signaling pathways in their cell interaction. Researchers were able to disrupt these pathways using a class of inhibitors typically used to treat advanced ...
Skin disease patients show response to targeted treatment
2025-02-03
PHOENIX — Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a chronic inflammatory skin condition of the skin, hair, nails, mouth and genitals. They described their findings in a study published in the Journal of Clinical Investigation that described their first-in-human, phase 2 clinical trial.
The researchers identified unique molecular and cellular changes in the skin with lichen planus, particularly an overactive immune response involving specific types of T cells, a crucial immune system component.
The ...
Tiny copper ‘flowers’ bloom on artificial leaves for clean fuel production
2025-02-03
Tiny copper ‘nano-flowers’ have been attached to an artificial leaf to produce clean fuels and chemicals that are the backbone of modern energy and manufacturing.
The researchers, from the University of Cambridge and the University of California, Berkeley, developed a practical way to make hydrocarbons – molecules made of carbon and hydrogen – powered solely by the sun.
The device they developed combines a light absorbing ‘leaf’ made from a high-efficiency solar cell material called perovskite, with a copper nanoflower catalyst, to convert carbon dioxide into useful molecules. Unlike most metal catalysts, which can only convert CO₂ into single-carbon ...
Cracks in Greenland Ice Sheet grow more rapidly in response to climate change
2025-02-03
Embargoed until 10am GMT UK time (5am US Eastern Time) on Monday 03 February 2025 (Nature Geoscience embargo)
-With pictures-
The Greenland Ice Sheet is cracking open more rapidly as it responds to climate change.
The warning comes in a new large-scale study of crevasses on the world’s second largest body of ice.
Using 3-D surface maps, scientists led by Durham University, UK, found crevasses had significantly increased in size and depth at the fast-flowing edges of the ice sheet over the ...
LAST 30 PRESS RELEASES:
Large study traces prehistoric human expansion into South America, where genomic studies have been lacking
Millions of previously undocumented genetic variants discovered in Brazil’s highly admixed population
Limited evidence for “escalator to extinction” in mountain ecosystems under climate change
Asians made humanity’s longest prehistoric migration and shaped the genetic landscape in the Americas, finds NTU Singapore-led study
OHSU study reveals impact of oft-overlooked cell in brain function
World’s largest bat organoid platform paves the way for pandemic preparedness
Mapping the genome of the Brazilian population, with implications for healthcare
Proof of concept for Amsterdam UMC-led HIV vaccination
MSK researchers identify key player in childhood food allergies: Thetis cells
Link between ADHD and obesity might depend on where you live
Scientists find two brain biomarkers in long COVID sufferers may be what’s causing their brain fog, other cognitive issues
Empowering cities to act: The Climate Action Navigator highlights where climate action is most needed
KAIST's pioneering VR precision technology & choreography tool receives spotlights at CHI 2025
Recently, a joint Chinese–American research team led by Dr. HU Han from the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences and Dr. Jingmai O’Conno
Nationally recognized emergency radiologist Tarek Hanna, MD, named new chair of Diagnostic Radiology & Nuclear Medicine at the University of Maryland School of Medicine
“Chicago archaeopteryx” unveiled: New clues on dinosaur–bird transition revealed by Chinese–American research team
‘Rogue’ immune cells explain why a gluten-free diet fails in some coeliac patients
World's first patient treated with personalized CRISPR gene editing therapy at Children’s Hospital of Philadelphia
Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment
Digital reconstruction reveals 80 steps of prehistoric life
GSA and GSA Foundation announce record support for the geosciences
UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center
NIH to award $8 million for new USC Superfund center to research and address ‘forever chemicals’
TMEM219 signaling promotes intestinal cell stem cell death and exacerbates colitis
MS heroes unite in Phoenix for CMSC 2025!
Stretched in a cross pattern: Our neighboring galaxy is pulled in two axes
Scientists find the ‘meow-tation’ that gives cats their orange fur
New stem cell model sheds light on human amniotic sac development
Shorter radiation therapy after prostate surgery safe, study finds
Long-term survival in patients with low-risk cervical cancer after simple, modified, or radical hysterectomy
[Press-News.org] Amazon Pharmacy's RxPass program improves medication adherence, helps prime members save money, study findsA study published in the Journal of the American Medical Association Network Open reveals enrollment in RxPass is associated with reduced out-of-pocket costs and higher medication refill rates, which help patients better manage disease.